Quick Answer
KIORA PHARMACEUTICALS INC reported Revenue (ASC 606) of $0.00 for fiscal year 2021.
KIORA PHARMACEUTICALS INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2021 | $0.00 | -100.0% |
| 2020 | $12.1K | -99.6% |
| 2019 | $2.69M | +62.5% |
| 2018 | $1.65M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2020 | $0.00 | — | — |
| June 30, 2020 | $0.00 | — | — |
| March 31, 2020 | $0.00 | -100.0% | — |
| September 30, 2019 | $0.00 | -100.0% | — |
| June 30, 2019 | $0.00 | — | -100.0% |
| March 31, 2019 | $2.69M | — | +754.1% |
| September 30, 2018 | $314.5K | — | — |
- KIORA PHARMACEUTICALS INC showed a decrease of -100.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2018–2021 period, KIORA PHARMACEUTICALS INC’s revenue (asc 606) has declined by 100.0% (from $1.65 million to $0.00).
- The most recent figure is from KIORA PHARMACEUTICALS INC’s fiscal year 2021 report (Form 10-K), filed with the SEC on April 15, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: